TCM
CGON icon

Tang Capital Management’s CG Oncology CGON Stock Holding History

Tang Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87,500
Closed -$3.52M – 100
2025
Q3 		$3.52M Hold
87,500
– – 0.14% 104
2025
Q2 		$2.27M Buy
+87,500
New +$2.11M 0.12% 114

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Tang Capital Management's CGON Position: Q4 2025 in Review

Tang Capital Management sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 87,500 shares — an estimated $3.52M sold.

Tang Capital Management first reported a position in CGON in Q2 2025 and held it in 2 quarters. The position peaked at $3.52M in Q3 2025. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • Tang Capital Management reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 87,500 CG Oncology shares in Q4 2025, an estimated $3.52M.
  • Tang Capital Management first reported a position in CG Oncology in Q2 2025 and held it in 2 quarters.
  • Tang Capital Management's CG Oncology position peaked at $3.52M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.